
Sign up to save your podcasts
Or


Kyle Wan, chairperson of the Academy's Life Experience and Assumptions Committee, explores what happens when one of humanity's greatest achievements, living longer, creates new financial and societal challenges. Kyle examines how longer lifespans, declining birth rates, medical advances, and an aging population could reshape retirement, insurance, and the systems people rely on as they grow older.
He also explores the important difference between lifespan and healthspan. It's not simply about how long we live, but how many of those years we spend in good health. He breaks down why mental health, social connection, retirement income, and quality of life become increasingly important as people live longer.
Additional Resources Explore the Actuaries Longevity Illustrator Learn about the Academy's Life Experience and Assumptions Committee Read the Contingencies Article "Golden Years Life Expectancy"In this episode of Actuary Voices: Policy Update, host Ted Gotsch speaks with Katie Dzurec, the Academy's director of public policy outreach, about key developments from the NAIC's 2026 Summer National Meeting in Columbus, Ohio. The conversation explores how affordability, accessibility and trust shaped discussions across insurance practice areas, from rising health care costs and homeowners insurance challenges to artificial intelligence, climate risk and financial regulation.
Katie also highlights the Academy's engagement with regulators throughout the meeting, work underway across health, life, property and casualty, and risk management and financial reporting, and what the Academy will be watching as the NAIC prepares for its Fall National Meeting in Dallas.
In this episode of Actuary Voices, Tiffany Eaton, actuary, educator, and board member of the Actuarial Foundation, shares her journey from aspiring math professor to actuary and how those experiences shaped her passion for helping students build confidence in math.
Tiffany explores why a growth mindset can make a difference in how students approach math, the importance of normalizing mistakes as part of learning, and how parents and educators can help students overcome the idea that they simply aren't "math people." She also discusses the Actuarial Foundation's work to expand opportunities for students through tutoring, competitions, scholarships, and mentorship. Additional Resources Explore the Academy's Student Resources Learn More About Volunteer Opportunities with The Actuarial Foundation Donate to the Actuarial FoundationIn this episode of Actuary Voices, Pietro Parodi, pricing actuary, author, and thought leader, shares his unconventional path into the actuarial profession, from studying physics and AI to becoming one of the industry's leading voices on pricing and actuarial modeling.
Pietro discusses why more data doesn't always lead to better decisions, the importance of building models that are both accurate and understandable, and how actuaries can avoid the trap of unnecessary complexity. He also shares his perspective on artificial intelligence, the value of critical thinking, and his widely used textbook, Pricing in General Insurance.
Additional Resources:
Read the Professionalism Discussion Paper: Roles of the Actuary Actuarial Models. Read the Resource & Discussion Guide: Actuarial Review of Investments in Actuarial Modeling Learn More About the Actuarial Stnadards Board's Modeling Actuarial Standard of Practice.
GLP-1 medications like Ozempic and Wegovy are making headlines for weight loss, but their potential impact goes far beyond the numbers on a scale. Could these drugs reshape health care spending, insurance coverage, longevity, and even the assumptions actuaries use to model risk?
In this episode of Actuary Voices, Contingencies Editor-in-Chief Preeti Vasishtha speaks with Dr. Kimberly Ferrero, the American Academy of Actuaries' Assistant Director of Research. Drawing on her background in cardiovascular and metabolic disease research, Dr. Ferrero explores the science behind GLP-1 therapies, the promises and uncertainties surrounding their long-term effects, and why actuaries are watching their rapid adoption so closely. The conversation examines affordability, insurer costs, mortality assumptions, patient behavior, health equity, and the question at the center of today's debate: Will the impressive results seen in clinical trials translate into lasting improvements at the population level?
Additional Resources:
Read Dr. Ferrero's article: How GLP-1 Drugs Are Shaping Care, Cost, and Coverage. Learn More About How Weightloss Drugs Effect Health care Costs in the Drivers of 2026 Premium Changes issue brief. Read Sam Gutterman's Last Word article on Weightloss Drugs, Weight and See?
Additional Resources:
Read the Academy's Issue Brief on Valuing Gender Expansive Data Read the Academy's Policy Paper on Social Security and Financially Disadvantaged Groups Learn more about the Sexuality and Gender Alliance of Actuaries (SAGAA)
If you or someone you know needs support, help is available in the United States by calling or texting 988.
From the publisher's feed